| |
Hormonal Control of Functional Uterine Bleeding* * The estrogen-progesterone-testosterone combinations used in our studies were supplied by the following pharmaceutical companies: Wyeth, Inc.: Tristerone (6 mg. estrone, 50 mg. progesterone, 25 mg. testosterone). Schering Corporation: Steratrin (1 mg. estradiol benzoate, 25 mg. progesterone, 25 mg. testoterone propionate). Sharp and Dohme, Inc.: Lukestra (1.66 mg. estradiol benzoate, 25 mg. progesterone, 25 mg. testosterone propionate). Ayerst, McKenna & Harrison Limited: Premarin Injectable, 20 mg. per vial of 5 c.c.
|
| |
|
|
| |
| Titel: |
Hormonal Control of Functional Uterine Bleeding* * The estrogen-progesterone-testosterone combinations used in our studies were supplied by the following pharmaceutical companies: Wyeth, Inc.: Tristerone (6 mg. estrone, 50 mg. progesterone, 25 mg. testosterone). Schering Corporation: Steratrin (1 mg. estradiol benzoate, 25 mg. progesterone, 25 mg. testoterone propionate). Sharp and Dohme, Inc.: Lukestra (1.66 mg. estradiol benzoate, 25 mg. progesterone, 25 mg. testosterone propionate). Ayerst, McKenna & Harrison Limited: Premarin Injectable, 20 mg. per vial of 5 c.c.
|
| Auteur: |
Greenblatt, Robert B.
Barfield, Wm. E.
|
| Verschenen in: |
American journal of obstetrics and gynecology
|
| Paginering: |
Jaargang 63 (1952) nr. 1 pagina's 5 p. |
| Jaar: |
1952
|
| Inhoud: |
|
| Uitgever: |
The C. V. Mosby Company
|
| Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften
|
| |
|
|
| |
|
Tijdschrift beschrijving